Reducing hospitalisation and antibiotic use in suspected early neonatal sepsis through serial measurements of C-reactive proteins

Hong Kong Journal of Paediatrics

Volumn 10, Issue 1, 2005, Pages

  Lee, W K ^a   Chan, M L ^a   Young, B W Y ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Acute phase reactant and protocol; C reactive protein; Infection; Newborn

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFOTAXIME; GENTAMICIN; METRONIDAZOLE; PENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; BIRTH WEIGHT; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL OBSERVATION; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NEWBORN; NEWBORN MORTALITY; NEWBORN SEPSIS; PRACTICE GUIDELINE; RETROSPECTIVE STUDY;

EID: 19744382776     PISSN: 10139923     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jason JM. Infectious disease-related deaths of low birth weight infants, United States, 1968 to 1982. Pediatrics 1989;84:296-303.
2. Stoll BJ, Gordon T, Korones SB, et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:72-80.
3. Kaftan H, Kinney JS. Early onset neonatal bacterial infections. Semin Perinatol 1998;22:15-24.
4. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep 1996;45(RR-7):1-24.
5. Hammerschlag MR, Klein JO, Herschel M, Chen FC, Fermin R. Patterns of use of antibiotics in two newborn nurseries. N Engl J Med 1977;296:1268-9.
6. Philip AG, Hewitt JR. Early diagnosis of neonatal sepsis. Pediatrics 1980;65:1036-41.
7. Goldmann DA, Leclair J, Macone A. Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr 1978;93:288-93.
8. Lacey RW. Evolution of microorganisms and antibiotic resistance. Lancet 1984;2:1022-5.
9. Low DE, Scheld WM. Strategies for stemming the tide of antimicrobial resistance. JAMA 1998;279:394-5.
10. Mathers NJ, Pohlandt F. Diagnostic audit of C-reactive protein in neonatal infection. Eur J Pediatr 1987;146:147-51.
11. Pourcyrous M, Bada HS, Korones SB, Barrett FF, Jennings W, Lockey T. Acute phase reactants in neonatal bacterial infection. J Perinatol 1991;11:319-25.
12. Da Silva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review. Pediatr Infect Dis J 1995;14:362-6.
13. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997;16:735-47.
14. Ehl S, Gering B, Bartmann P, Hogel J, Pohlandt F. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997; 99:216-21.
15. Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998;102:E41.
16. Rodwell RL, Leslie AL, Tudehope DI. Early diagnosis of neonatal sepsis using a hematologic scoring system. J Pediatr 1988;112: 761-7.
17. Singh M, Narang A, Bhakoo ON. Predictive perinatal score in the diagnosis of neonatal sepsis. J Trop Pediatr 1994;40:365-8.
18. Dobson SR, Isaacs D, Wilkinson AR, Hope PL. Reduced use of surface cultures for suspected neonatal sepsis and surveillance. Arch Dis Child 1992;67(1 Spec No):44-7.
19. Wagle S, Grauaug A, Kohan R, Evans SF. C-reactive protein as a diagnostic tool of sepsis in very immature babies. J Paediatr Child Health 1994;30:40-4.
20. Bomela HN, Ballot DE, Cory BJ, Cooper PA. Use of C-reactive protein to guide duration of empiric antibiotic therapy in suspected early neonatal sepsis. Pediatr Infect Dis J 2000;19: 531-5.
21. Philip AG, Mills PC. Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics 2000;106:E4.